Skip to main content

Home/ Cancer/ Group items tagged res

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. - Cance... - 0 views

cancerres.aacrjournals.org/...5617

2005 August study research in_vitro in_vivo humans cannabinoids angiogenesis antiangiogenic VEGF inhibition inhibitorVEGFR-2 cancer glioma medline

shared by Matti Narkia on 21 Mar 09 - Cached
  • Matti Narkia on 21 Mar 09
     
    Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M. Cancer Res. 2004 Aug 15;64(16):5617-23. PMID: 15313899
Matti Narkia

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2... - 0 views

cancerres.aacrjournals.org/...1945

2008 March study research in_vtro in_vivo animal_study mice cannabis cannabinoids marijuana cancer anti-cancer anticancer medline glioma MMP-2 invasion anti-invasive angiogenesis

shared by Matti Narkia on 21 Mar 09 - Cached
  • Matti Narkia on 21 Mar 09
     
    Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Blázquez C, Salazar M, Carracedo A, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M. Cancer Res. 2008 Mar 15;68(6):1945-52. PMID: 18339876 doi: 10.1158/0008-5472.CAN-07-5176
Matti Narkia

Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a ... - 0 views

www.ncbi.nlm.nih.gov/...12148580

2002 June study research in_vivo animal_study mice mushroom mushrooms fungus Phellinus_rimosus cisplatin chemotherapy cancer nephrotoxicity nutrition extract kidney

shared by Matti Narkia on 21 Mar 09 - No Cached
  • Matti Narkia on 21 Mar 09
     
    Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus.\nAjith TA, Jose N, Janardhanan KK.\nJ Exp Clin Cancer Res. 2002 Jun;21(2):213-7.\nPMID: 12148580
Matti Narkia

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxyg... - 0 views

clincancerres.aacrjournals.org/...5930

2004 September study research in_vitro EGFR tyrosine_kinase inhibitors inhibitor inhibition TKI TKIs Iressa gefitinib COX-2 celecoxib Celebre3x Celebra head_and_neck_cancer head_and_neck cancer SCCHN SCC HNCA synergy medicine head neck oncology

shared by Matti Narkia on 15 Mar 09 - Cached
  • Matti Narkia on 15 Mar 09
     
    Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM. Clin Cancer Res. 2004 Sep 1;10(17):5930-9. PMID: 15355926
Matti Narkia

Phase II study of pomegranate juice for men with rising prostate-specific antigen follo... - 0 views

clincancerres.aacrjournals.org/...4018

2006 July study research clinical_trial humans pomegranate juice cancer prostate PSA nutrition diet medicine medical prostate_cancer medline

shared by Matti Narkia on 25 Feb 09 - Cached
  • Matti Narkia on 25 Feb 09
     
    Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. Clin Cancer Res. 2006 Jul 1;12(13):4018-26. PMID: 16818701
Matti Narkia

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer -- Redman ... - 0 views

clincancerres.aacrjournals.org/...1666

Phase-II phaseII Trial Tetrathiomolybdate Advanced Kidney Cancer renal kidneycancer clinicaltrial anti-angiogenesis anti-angiogenic anti-copper agent angiogenesis copper inhibition inhibitor inhibitors reduction medicine medline oncology science study res

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    B. G. Redman, P. Esper, Q. Pan, R. L. Dunn, H. K. Hussain, T. Chenevert, G. J. Brewer, and S. D. Merajver Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer Clin. Cancer Res., May 1, 2003; 9(5): 1666 - 1672.
Matti Narkia

Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus)... - 0 views

cancerres.aacrjournals.org/...12026

2006 December study research in_vitro in_ivo animal white button mushroom extract white_button_mushroom Agaricus_bisporus Agaricus mushrooms herb herbs anti-aromatase activity aromatase breast cancer breast_cancer growth-inhibitory medline nutrition

shared by Matti Narkia on 16 Apr 09 - Cached
  • Matti Narkia on 16 Apr 09
     
    Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Chen S, Oh SR, Phung S, Hur G, Ye JJ, Kwok SL, Shrode GE, Belury M, Adams LS, Williams D. Cancer Res. 2006 Dec 15;66(24):12026-34. PMID: 17178902 doi: 10.1158/0008-5472.CAN-06-2206
Matti Narkia

Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis... - 0 views

www.ncbi.nlm.nih.gov/...16619514

2006 March study review cancer immunology immune function immunity Th1_Th2 Th1:Th2 balance Th1 Th2 CD4 CD8 IL-2 IL-12 IFN-gamma medline IL-4 Il-5 IL-6 IL-10 IL-13 CpG oligodeoxynucleotides ODN biotherapy

shared by Matti Narkia on 14 Apr 09 - No Cached
  • Matti Narkia on 14 Apr 09
     
    Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications. Becker Y. Anticancer Res. 2006 Mar-Apr;26(2A):1113-34. Review. PMID: 16619514
Matti Narkia

Lysis of tumor cells by natural killer cells in mice is impeded by platelets. - Cancer ... - 0 views

cancerres.aacrjournals.org/...1295

1999 March study research in_vitro in_vivo animal_study natural_killer_cells NK_cells cytotoxicity lysis cancer tumor cells impeded platelets platelet-impeded platelet aggregation platelet_aggregation medline metastasis

shared by Matti Narkia on 13 Apr 09 - Cached
  • Matti Narkia on 13 Apr 09
     
    Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Nieswandt B, Hafner M, Echtenacher B, Männel DN. Cancer Res. 1999 Mar 15;59(6):1295-300. PMID: 10096562
Matti Narkia

Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostat... - 0 views

clincancerres.aacrjournals.org/...1078-0432.CCR-08-2503v1

2009 March study research epidemiological case-control humans men prostate cancer prostate_cancer advanced agressive risk cancer_risk omega-3 PUFA risk_reduction long-chain EPA DHA COX-2 gene genetics nutrition medline inflammation PCa

shared by Matti Narkia on 28 Mar 09 - Cached
  • Matti Narkia on 28 Mar 09
     
    Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostate Cancer Risk. Fradet V, Cheng I, Casey G, Witte JS. Clin Cancer Res. 2009 Mar 24. [Epub ahead of print] PMID: 19318492 DOI: 10.1158/1078-0432.CCR-08-2503
Matti Narkia

Selenium and immunocompetence in patients with head and neck cancer. - Biol Trace Elem ... - 0 views

www.springerlink.com/...975371n8445363vp

2000 February study clinical_trial rct humans medline nutrition selenium sodium_selenite immunity anergy cell-mediated immune response CMIR head_and_neck cancer head_and_neck_cancer scchn scc hnca therapy treatment supplementation

shared by Matti Narkia on 10 Apr 09 - Cached
  • Matti Narkia on 10 Apr 09
     
    Selenium and immunocompetence in patients with head and neck cancer. Kiremidjian-Schumacher L, Roy M, Glickman R, Schneider K, Rothstein S, Cooper J, Hochster H, Kim M, Newman R. Biol Trace Elem Res. 2000 Feb;73(2):97-111. PMID: 11049203 DOI: 10.1385/BTER:73:2:97
Matti Narkia

Vitamin D and cancer Ali MM, Vaidya V - J Can Res Ther 2007 Oct-Dec - 0 views

www.cancerjournal.net/article.asp

2007 October study review vitamin D vitamin_D cancer VDR anticancer anti-cancer calcitriol 1.25(OH)2D paricalcitol analogues prostate_cancer prostate PCa mechanism mechanisms risk angiogenesis deficiency doses dosing tocixity colorectal_cancer

shared by Matti Narkia on 09 Apr 09 - Cached
  • Matti Narkia on 09 Apr 09
     
    Vitamin D and cancer. Ali MM, Vaidya V. J Cancer Res Ther. 2007 Oct-Dec;3(4):225-30. Review. PMID: 18270398 DOI: 10.4103/0973-1482.38998
Matti Narkia

An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of o... - 0 views

www.ncbi.nlm.nih.gov/...17302200

2007 study review humans estimate cancer mortality rate reductions reduction oral vitamin_D supplementation nutrition Grant Garland medline Europe USA

shared by Matti Narkia on 15 Sep 09 - No Cached
  • Matti Narkia on 15 Sep 09
     
    An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Grant WB, Garland CF, Gorham ED. Recent Results Cancer Res. 2007;174:225-34. Review. PMID: 17302200
Matti Narkia

Meta-analysis of vitamin D, calcium and the prevention of breast cancer. - [Breast Canc... - 0 views

www.ncbi.nlm.nih.gov/...19851861

2009 October study review meta-analysis vitamin_D 25ohd calcium breast cancer breast_cancer prevention risk nutrition medline

shared by Matti Narkia on 24 Oct 09 - No Cached
  • Matti Narkia on 24 Oct 09
     
    Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Breast Cancer Res Treat. 2009 Oct 23. [Epub ahead of print] PMID: 19851861 These results provide strong evidence that vitamin D and calcium have a chemopreventive effect against breast cancer.
Matti Narkia

Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs - 0 views

cancerres.aacrjournals.org/...8031

2008 October study in_vitro vitamin C vitamin_C nutrition cancer reactive_oxygen_species ROS mitochondria apoptosis chemotherapy drugs Antagonizes doxorubicin cisplatin vincristine methotrexate imatinib leukemia lymphoma medline supplementation in_vivo

shared by Matti Narkia on 08 Mar 09 - Cached
  • Matti Narkia on 08 Mar 09
     
    Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.\nHeaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, O'Connor OA.\nCancer Res. 2008 Oct 1;68(19):8031-8.\nPMID: 18829561
Matti Narkia

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agent... - 0 views

www.sciencedirect.com/science

2009 February study review cannabinoid agonists cannabinoid_agonists cannabinoids CB receptors cancer anti-cancer anticancer inflammation angiogenesis antiangiogenic nausea pain medline therapy treatment cannabis

shared by Matti Narkia on 21 Mar 09 - Cached
  • Matti Narkia on 21 Mar 09
     
    Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M. Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):117-31. PMID: 19285265 doi:10.1016/j.beem.2009.02.001    
Matti Narkia

An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of o... - 0 views

www.ncbi.nlm.nih.gov/...query.fcgi

oral cholecalciferol cancer mortality reduction study science nutrition medicine peer-reviewed medline pubmed supplement supplements imported delicious vitamin_D vitamin D3

shared by Matti Narkia on 24 Feb 09 - No Cached
  • Matti Narkia on 24 Feb 09
     
    Grant WB, Garland CF, Gorham ED. An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Recent Results Cancer Res. 2007;174:225-34. PMID: 17302200 [PubMed - in process]
Matti Narkia

Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficie... - 0 views

cancerres.aacrjournals.org/...6745

2007 July study research in_vitro in_vivo animal_study mice antidiabetic drug metformin p53-deficient p53 deficient cancer growth-inhibitory anticancer anti-cancer anti-diabetic diabetes type_2 medicine medline AMPK ATP AICAR

shared by Matti Narkia on 04 Jun 09 - Cached
  • Matti Narkia on 04 Jun 09
     
    Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B, Thompson CB. Cancer Res. 2007 Jul 15;67(14):6745-52. PMID: 17638885 doi: 10.1158/0008-5472.CAN-06-4447
Matti Narkia

Antitumor Activity of Human Papillomavirus Type 16 E7-Specific T Cells against Virally ... - 0 views

cancerres.aacrjournals.org/...11146

2005 December study research clinical_trial humans patients HPV virus head_and_neck_cancer cancer scchn hnca scc immunity immune system immunology medline immunotherapy HPV-16 T_cells

shared by Matti Narkia on 11 Aug 09 - Cached
  • Matti Narkia on 11 Aug 09
     
    Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL. Cancer Res. 2005 Dec 1;65(23):11146-55. PMID: 16322265
Matti Narkia

Cancer Journal: Latest cancer research Bio-engineered proteins: trial confirms new way ... - 0 views

www.ecancermedicalscience.com/news-insider-news.asp

2009 March news cancer animal_study mice Bio-engineered proteins tumour_inhibiting_protein von_Hippel-Lindau VHL growth-inhibitory experimental treatment anti-cancer strategy hypoxia-inducible_factor HIF

shared by Matti Narkia on 26 Mar 09 - Cached
  • Matti Narkia on 26 Mar 09
     
    Re-engineering a protein that helps prevent tumours spreading and growing has created a potentially powerful therapy for people with many different types of cancer. In a study published in the first issue of EMBO Molecular Medicine, Canadian researchers modified the tumour inhibiting protein, von Hippel-Lindau (VHL), and demonstrated that it could suppress tumour growth in mice.
1 - 20 of 28 Next ›
Showing 20▼ items per page